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Alcohol consumption is customary in most cultures and alcohol abuse is common world-
wide. For example, more than 50% of Americans consume alcohol, with an estimated
23.1% of Americans participating in heavy and/or binge drinking at least once a month. A
safe and effective therapy for alcoholic liver disease (ALD) in humans is still elusive, despite
signiﬁcant advances in our understanding of how the disease is initiated and progresses. It
is now clear that acute alcohol binges not only can be acutely toxic to the liver, but also can
contribute to the chronicity of ALD. Potential mechanisms by which acute alcohol causes
damage include steatosis, dysregulated immunity and inﬂammation, and altered gut per-
meability. Recent interest in modeling acute alcohol exposure has yielded new insights
into potential mechanisms of acute injury, which also may well be relevant for chronic ALD.
Recent work by this group on the role of PAI-1 and ﬁbrin metabolism in mediating acute
alcohol-induced liver damage serve as an example of possible new targets that may be
useful for alcohol abuse, be it acute or chronic.
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INTRODUCTION
Alcohol consumption is customary in most cultures and alcohol
abuse is common worldwide. For example, more than 50% of
Americans consume alcohol, with an estimated 23.1% of Amer-
icans participating in heavy and/or binge drinking at least once
a month (Substance Abuse and Mental Health Services Adminis-
tration, 2011). The detrimental effects of drinking alcohol, par-
ticularly heavy and/or chronic consumption, are well established.
The most commonly recognized symptoms of alcohol consump-
tion are associated with chronic alcoholism, and it is a causal/risk
factor in over 60 major types of diseases. These and other effects
of alcohol consumption have made alcohol the third leading risk
factor globally for disease and disability (World Health Organi-
zation, 2011). The cost of medical consequences of alcohol abuse
have been projected to be more than 26 billion dollars in the US in
1998, making it a signiﬁcant ﬁnancial burden for the health care
system (U. S. Department of Health and Human Services, 2000).
These estimates take into account only direct medical expenses; it
is estimated that the cost of lost productivity due to alcohol-related
illness was ∼90 billion dollars in the US in 1998. Thus, the med-
ical consequences of alcohol consumption have signiﬁcant societal
consequences in addition to the effects on the individual.
The liver is the main site of alcohol metabolism and a major
target organ of alcohol-induced injury. The susceptibility of the
liver to alcohol-induced toxicity is due to both the high concentra-
tions of alcohol found in the portal blood (versus systemic), as well
as the metabolic consequences of ethanol metabolism. Alcoholic
Liver Disease (ALD) is a spectrum of disease states that includes
steatosis (fatty liver), steatohepatitis, and in severe cases, ﬁbrosis
and/or cirrhosis. Steatosis, characterized by fat accumulation in
hepatocytes, develops in 90% of individuals who drink more than
16 g of alcohol/day (Crabb, 1999), but resolves upon cessation of
alcohol consumption (Bergheim et al., 2005). In only aminority of
even heavy drinkers, steatosis progresses to steatohepatitis, which
is characterized by the persistence of fatty liver accompanied by
inﬂammation. In later stages of ALD, collagen deposition and
regenerative nodules can result in the development of ﬁbrosis
and cirrhosis, respectively. Abstinence from alcohol is beneﬁcial
for patients in all stages of ALD and is necessary to prevent
progression of liver injury in those with early stages of disease
(Bergheim et al., 2005). Unfortunately, a high rate of recidivism
among chronic alcohol abusers greatly reduces the opportunity for
disease remission via abstinence. Therefore, better understand-
ing of the mechanisms by which alcohol damages the liver may
yield newpharmacologic strategies to blunt, halt, or reverse disease
progression, potentially even in inveterate alcoholics.
Although alcohol exposure has been studied for decades, most
work has focused on chronic exposure and our understanding of
the mechanisms and effects of acute alcohol exposure are lacking.
Acute alcohol exposure, commonly known as “binge drinking,” is
deﬁned by theNational Survey onDrugUse andHealth (NSDUH)
as ﬁve or more drinks on a single occasion, within a time period
of 3 h. However, acute alcohol exposure can also include a period
of heavy drinking that may span several days or periods of inter-
mittent, repeated episodes of heavy drinking. For example, in the
clinical setting an episode of “binge” drinking often describes a
period of alcohol consumption and intoxication that lasts upward
of 2 days (Weschsler and Austin, 1998). The NSDUH in 2010
showed that more than 58 million Americans have participated
in binge drinking on at least one occasion within 30 days (Sub-
stance Abuse and Mental Health Services Administration, 2011).
Due to the increasing prevalence of binge drinking in people
aged 18–25, greater interest has turned toward the effects of acute
alcohol exposure.Although chronic alcohol abuse is themost com-
monly recognized source of illness causedby alcohol consumption,
acute alcohol abuse is also detrimental.Many acute alcohol-related
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deaths are due to severe CNS depression, which slows motor coor-
dination and respiratory rates.Acute alcohol exposure also impairs
recovery from infection and trauma and delays wound healing
(Radek et al., 2005, 2012). As such, acute alcohol consumption
is a major underlying cause of morbidity and mortality during
hospital admittance (Jones et al., 1991).
ACUTE ALCOHOL-INDUCED LIVER INJURY
The current understanding of the effects of binge drinking on liver
injury is not as complete as our knowledge regarding the effects
of chronic ethanol exposure. There are, however, some parallels
between acute and chronic alcohol exposure. Potential mecha-
nisms by which acute alcohol causes liver injury are discussed
below.
MECHANISMS OF STEATOSIS
As mentioned above, the ﬁrst and most common hepatic change
caused by alcohol consumption is steatosis, or fatty liver. Fat
accumulation can be both macrovesicular (having one large fat
droplet per hepatocyte and lateral displacement of the nucleus)
or microvesicular (many small fat droplets per hepatocyte; Ishak
et al., 1991). One mechanism by which alcohol exposure causes
steatosis is directly via alcohol metabolism. Concentrations of
alcohol can easily reach the mM range in the portal/hepatic circu-
lation during alcohol consumption. In the process of metabolizing
ethanol to acetate, two equivalents of reduced NADH are gener-
ated per equivalent of ethanol oxidized. This metabolism robustly
increases the ratio of NADH:NAD+ within the cell, which then
inhibits the β-oxidation of fatty acids in the liver. Furthermore,
ethanol metabolism also increases the rate of esteriﬁcation of fatty
acids (Ontko, 1973). The net effect is to favor fat accumulation in
the hepatocytes.
While alcohol metabolism may be sufﬁcient to cause fat accu-
mulation, it is not the onlymechanismbywhich steatosis develops.
Blocking lipopolysaccharide (LPS) signaling (Yin et al., 2001) and
pro-oxidant producing enzymes (Kono et al., 2000; McKim et al.,
2003) in rodents via genetic alterations also protect against steato-
sis, without altering ethanol metabolism. Fat accumulation can
also be stimulated by mediators that alter lipid metabolism, such
as pro-inﬂammatory cytokines (Grunﬁeld et al., 1990). Signaling
downstream of these cytokines contributes to hepatic fat accumu-
lation in two ways – by increasing the deposition of fatty acids,
and decreasing the breakdown and secretion of lipids into the
circulation. For example, TNFα increases free fatty acid release
from peripheral adipocytes (Hardardottir et al., 1992), increases
de novo lipid synthesis (Feingold andGrunfeld, 1987), and inhibits
β-oxidation of fatty acids (Nachiappan et al., 1994). Ultimately,
these changes stimulate fat accumulation in the liver by increasing
fatty acid supply, and concomitantly impairs the liver’s capacity
for fatty acid metabolism and secretion.
Hepatic steatosis develops acutely in themajority of individuals
consuming even moderate amounts of alcohol. Steatotic changes
are also seen in rodentmodels of binge drinking (Kaiser et al., 2009;
Donohue et al., 2011). Steatosis is considered an asymptomatic dis-
ease state, which readily reverses with abstinence (Bergheim et al.,
2005). Indeed, at the level of the organism, hepatic steatosis can
be viewed as a protective measure, as it partitions lipids away from
the blood and stores them for potential later use (van Ginneken,
2008). However, although steatosis is an inert pathology per se, it
sensitizes the liver to injury caused by a second insult (Day and
James, 1998). According to this “two-hit hypothesis,” alcohol con-
sumption alone does not cause progression of ALD from steatosis
to steatohepatitis, cirrhosis, or ﬁbrosis; rather, a second risk fac-
tor or insult is required for development of later stages of disease.
Such a second insult could include an inﬂammatory response,
reactive oxygen species, or hypoxia, among others. For example,
acute ethanol exposure is well known to enhance liver pathol-
ogy induced by xenobiotics, such as bacterial cell wall products
(e.g., lipopolysaccharide). Furthermore, acute alcohol consump-
tion itself could provide the second hit; for example, an episode of
binge drinking can trigger entry into acute alcoholic hepatitis in a
chronic alcoholic (Rivara et al., 1993; Barrio et al., 2004).
DYSREGULATION OF IMMUNITY AND INFLAMMATION
The two-hit hypothesis ismirrored on amolecular level by the con-
cepts of “priming”and“sensitization”which are now considered to
be fundamental to alcohol-induced liver injury (Tsukamoto et al.,
2001). Here,“priming”refers to the ability of ethanol pre-exposure
to cause inﬂammatory cells of the liver (e.g., Kupffer cells) to
more robustly release pro-inﬂammatory cytokines in response to
a second stimulus, such as LPS. Alcoholic hepatitis patients have
larger amounts of circulatingTNFαboth basally and after stimulus
(McClain and Cohen, 1989). Additionally, ethanol pre-exposure
can prime Kupffer cells to LPS stimulation, resulting in enhanced
TNF-α release (Enomoto et al., 1998). Ethanol can also sensi-
tize cells, causing cell populations downstream of inﬂammatory
cytokine signaling to respond more robustly. Patients with fatty
liver are more sensitive to LPS-induced liver injury (Yang et al.,
1997). This sensitization to LPS is recapitulated in rodent models
of acute alcohol exposure (Bergheim et al., 2006; Beier et al., 2009).
Although some studies have shown that alcohol exposure
primesmacrophages to inducemore inﬂammatory tissue damage,
others have shown that acute alcohol intoxication (i.e., when alco-
hol is present in the system) actually impairs the immune response.
For example, binge drinking increases the risk of infection (e.g.,
Gentilello et al., 1993; Gamble et al., 2006; Grifﬁn et al., 2009).
Furthermore, acute ethanol consumption worsens the prognosis
of sepsis (Lin et al., 2009). A major mechanism by which alcohol
can impair the immune response is via altering Toll-like recep-
tor (TLR) signaling, which serve as pattern recognition receptors
on macrophages and other cells of the innate immune system
(Beutler, 2009). TLRs are involved in both direct cytotoxic and
effector responses of macrophages, and therefore serve as key
early initiators of an appropriate immune response. Importantly,
ethanol intoxication has been shown to blunt the stimulation of
macrophages by a number of TLR ligands, including zymosan A
(TLR2) and LPS (TLR4; Pruett et al., 2004; Goral and Kovacs,
2005).
Although it may seem that these effects of acute ethanol on
macrophage responsiveness are contradictory (i.e., both impairing
and priming the macrophages), the timing of the inﬂammatory
stimulus relative to ethanol exposure seems to be important.
For example, acute ethanol (4–6 g/kg) blunted inﬂammatory liver
damage caused by LPS, when LPS was injected 3 h after ethanol
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exposure (during intoxication), but enhanced damage if the LPS
was administered 24 h after ethanol (Enomoto et al., 1998). The
mechanisms by which acute ethanol causes both tolerance and
priming of the innate immune system are still incompletely under-
stood. However, it is clear that acute alcohol exposure produces
a dangerous situation in which the likelihood of infection is
increased during acute intoxication, but liver damage is enhanced
by the inﬂammatory response to that infection.
GUT PERMEABILITY AND ENDOTOXIN
Even in the absence of infection, alcohol can alter the response
to inﬂammatory stimuli. The association between increased cir-
culating bacterial endotoxin (i.e., LPS) and liver injury has been
established since the 1970s (Nolan, 2010). Circulating levels of
LPS are increased in ALD patients (Bode et al., 1987; Fukui
et al., 1991) as well as in experimental models of both acute
(Lambert et al., 2003) and chronic (Nanji et al., 1994; Keshavarz-
ian et al., 2001) alcohol consumption. Increased circulating LPS
in response to alcohol consumption is due, at least in part, to
increased gut permeability, which thereby allows translocation of
LPS into the portal blood. In fact, elimination of intestinal bac-
teria reduces alcohol-induced liver injury via reduced circulating
endotoxin levels in mice (Nanji et al., 1994). Experimental models
of both chronic (Mathurin et al., 2000; Tamai et al., 2002) and
acute (Tamai et al., 2000; Lambert et al., 2003) alcohol exposure
showed that alcohol increased permeation of LPS. Acute alcohol
consumption increased circulating levels of LPS in both healthy
volunteers and alcoholics with ALD (Bode et al., 1987; Fukui et al.,
1991).
Under normal conditions, the spaces between epithelial cells
that make up the intestinal barrier are sealed by tight junctions.
These tight junctions prevent transfer of toxic compounds, like
LPS, into the circulation (Purohit et al., 2008). Changes in intesti-
nal permeability caused by ethanol may be due in part to the
disruption of apical junctional proteins in the small intestine.
In vitro studies using Caco-2 enterocytes showed that alcohol
can disrupt ZO-1 tight junctions, ultimately causing gaps in
the paracellular space (Ma et al., 1999). Furthermore, chronic
alcohol exposure reduces ZO-1 and occludin in the ileum of
mice (Zhong et al., 2010). The same studies also demonstrated
that the reduction in tight junction proteins was associated with
oxidative stress in the intestine. Potential sources of oxidative
stress in the GI tract after alcohol exposure include acetalde-
hyde and nitric oxide (Purohit et al., 2008). Similar mecha-
nisms may be involved in gut permeability due to acute alcohol
exposure.
SUMMARY
Taken together, acute alcohol exposure can cause a “perfect storm”
that favors inﬂammatory liver damage. Acute alcohol exposure
enhances the risk of infection and permeability of the GI tract.
Either or both mechanisms will increase the delivery of TLR
ligands to macrophages in the liver. At later times after alcohol
exposure, the inﬂammatory response of macrophages to TLR lig-
ands is primed, and more cytotoxic cytokines (e.g., TNFα) are
produced. Furthermore, steatosis in parenchymal cells sensitizes
them to cytotoxic killing by the cytokines released bymacrophages.
MODELS OF ACUTE ETHANOL EXPOSURE
The majority of research on alcoholic liver injury has investi-
gated the effects of chronic alcohol consumption.However, clinical
evidence highlighting the detrimental effects of acute alcohol con-
sumption has spurred recent interest in experimental models
of binge drinking, intermittent heavy drinking, and other acute
alcohol exposures. These models include in vitro and in vivo par-
adigms, with the latter spanning many species including rodents,
dogs, primates, and micropigs (Dolganiuc and Szabo, 2009). The
majority of acute alcohol research is performed in rodent models.
Such models achieve pathological states (e.g., steatosis, inﬂamma-
tion) that resemble the early stages of liver injury seen in humans.
The use of rodents by the research community has increased since
the development of a variety of knockout and other genetically
modiﬁedmouse strains that allow formore convenient and speciﬁc
mechanistic studies.
One of the major obstacles in rodent models of alcohol expo-
sure is their aversion to ethanol. Rodents do not voluntarily
consume alcohol at concentrations that will recapitulate liver dis-
ease found in humans. Therefore, forced bolus administration by
intragastric gavage is the most common approach to modeling
acute alcohol abuse (Siegmund et al., 2005). Rodent models of
acute alcohol exposure often fall into one of three categories: sin-
gle bolus dose models, multiple bolus dose models, and “2-hit”
models. Ethanol is administered at bolus doses of up to 6 g/kg,
which takes into account differences in ethanol kinetics in rodents
versus humans (Gershman and Steeper, 1991; Carson and Pruett,
1996). The peak concentrations of alcohol in rodents are similar
to those achievable in humans during an acute alcohol binge.
Chronic models are costly, and it is often difﬁcult to distin-
guish between effects and proximate causes in chronic models of
liver damage. In addition to studying acute hepatotoxicity, acute
models are therefore also useful as a screening tool and/or mech-
anistic analysis to complement chronic studies. This approach
is supported by the observation that animals exposed to acute
alcohol administration develop steatosis and inﬂammation in a
manner similar to animals in chronic ethanol studies. Further
strengthening this idea of “a model of a model” is the mechanis-
tic overlap of protective agents in both acute and chronic alcohol
exposure models. For example, Enomoto et al. (2000) demon-
strated that compounds known to protect against liver damage in
chronic exposure models [e.g., GdCl3 (Adachi et al., 1994), antibi-
otics (Adachi et al., 1995), nimodipine (Iimuro et al., 1996)] were
also protective against steatosis in a rat model of acute ethanol
exposure. Because of their use as models of chronic alcohol expo-
sure, acute models of alcohol exposure are particularly valuable
for screening compounds that may offer therapeutic beneﬁt, as
well as for the investigation of new mechanisms downstream of
therapeutic compounds. Thus far, acute alcohol exposure models
have lent few false positives when used to screen for efﬁcacy of
therapeutic molecules for chronic study.
PAI-1 AND FIBRIN – NEW MEDIATORS IN ACUTE
ALCOHOL-INDUCED LIVER INJURY
PLASMINOGEN ACTIVATOR INHIBITOR-1
Plasminogen activator inhibitor-1 (PAI-1) is an acute phase pro-
tein that plays an important role in injury and inﬂammation, at
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least in part via regulation of ﬁbrinolysis. PAI-1 prevents the acti-
vation of plasmin and subsequent degradation of ﬁbrin into ﬁbrin
degradationproducts (FDP)by inhibiting both the urokinase-type
and tissue-type plasminogen activators (uPA and tPA; Figure 1;
Kruithof, 1988). A role for PAI-1 in alcohol-induced liver injury
was ﬁrst seen in cirrhotic patients, who had an increased PA:PAI-1
ratio (Violi et al., 1992; Hu et al., 2001), resulting in hyperﬁb-
rinolysis. In contrast, during the development of ALD, levels of
circulating PAI-1 are elevated and the PA:PAI-1 is lower, favoring
hypoﬁbrinolysis (Marques-Vidal et al., 1995; Dimmitt et al., 1998;
Mukamal et al., 2001). Levels of PAI-1 correlate with the degree
of lipid accumulation in experimental models of alcohol-induced
liver steatosis (Alessi et al., 2003), and may be used as an index of
severity of later stages of ALD (Tran-Thang et al., 1989).
While its importance in some diseases (e.g., atherosclerosis) has
been established, the role of PAI-1 in ALD is still unclear. Stud-
ies using knockout mice strains, particularly PAI-1−/− mice, have
begun to clarify the role of PAI-1 in lipid accumulation. Ma et al.
(2004) showed that PAI-1−/− mice were protected from hepatic
lipid accumulation in a model of high fat/high carbohydrate diet
induced obesity. Additionally, our group has shown that both
acute and chronic ethanol-induced steatosis correlate with hepatic
PAI-1 expression, and that blocking PAI-1, either pharmacologi-
cally or genetically, confers protection against steatosis (Bergheim
et al., 2006). In this study, TNFR1−/− mice were also protected
against steatosis with concomitant blunting of PAI-1 (Bergheim
et al., 2006), which suggests that the mechanism of PAI-1 induc-
tion after alcohol exposure is downstream of TNFα, possibly via
MAPK signaling (Fearns and Loskutoff, 1997). PAI-1 also appears
to be critical in mediating organ inﬂammation. For example,mice
lacking PAI-1 were protected against leukocyte inﬁltration and
tissue damage in a model of glomerulonephritis (Kitching et al.,
2003). Work in this laboratory has shown that PAI-1−/− mice
were nearly completely protected against inﬂammation caused by
chronic alcohol (Arteel, 2008).HowPAI-1mediates inﬂammation,
particularly after alcohol exposure, remains unclear. One potential
mechanism is that PAI-1 mediates changes in the proteolytic acti-
vation/deactivation of cytokines important in the inﬂammatory
response. These effects could include prevention of the activa-
tion of cytokines including transforming growth factor-β (Espevik
et al., 1987; Sato et al., 1990), or stabilization of pro-inﬂammatory
cytokines, such as the chemoattractant IL-8 (Marshall et al., 2003).
FIBRIN
Another potentialmechanismunderlying the inﬂammatory effects
of PAI-1 involves impaired ﬁbrinolysis and subsequent ﬁbrin accu-
mulation (Holdsworth et al., 1979; Loike et al., 1995). Fibrin(ogen)
is a structural component of the extracellularmatrix (ECM).Upon
activation of the coagulation cascade, the latent form, ﬁbrinogen,
is cleaved by thrombin into the active form, ﬁbrin (Figure 1).
Fibrin can crosslink to create clots or be degraded by plasmin
into ﬁbrinogen degradation products. In addition to its role in
hemostasis, ﬁbrin can also function as a signaling molecule via
interaction with cell surface receptors. Fibrin’s role in inﬂam-
mation has been highlighted by its ability to exert a myriad of
pro-inﬂammatory effects. For example, Qi et al. (1997) showed
that ﬁbrin induces IL-8 expression in vascular endothelial cells.
Fibrin matrices can regulate the migration of inﬂammatory cells
FIGURE 1 | Effects of LPS and ethanol on PAI-1 and fibrinolysis. Activation
of the coagulation cascade by LPS via thrombin results in accumulation of
cross-linked ﬁbrin. Cross-linked ﬁbrin is degraded by plasmin. PAI-1 blocks
ﬁbrinolysis by inhibiting the plasminogen activators uPA and tPA and therefore
the activation of plasmin. Both ethanol and LPS can modulate signaling
downstream of the coagulation cascade, increasing ﬁbrin deposition. Ethanol
may also blunt ﬁbrin degradation by altering signaling downstream of TNFα.
LPS can have similar effects on ﬁbrinolysis by stimulating release of TNFα.
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in vitro, including IL-8-stimulated neutrophils (Loike et al., 1995).
Additionally, deﬁbrillation reduces macrophage migration in the
kidney (Holdsworth et al., 1979).
Fibrin has been shown to have a direct role in experimen-
tal ALD as well. Our group has shown that ﬁbrin deposition
in hepatic sinusoids is increased by chronic ethanol consump-
tion (Figure 2) and that ﬁbrin accumulation correlates with
inﬂammation in an acute-exposuremodel of alcohol-induced liver
injury. Furthermore, blocking ﬁbrin deposition either directly,
using the thrombin inhibitor Hirudin, or indirectly, using the
MEK-inhibitor U0126, protected against enhanced liver injury
caused by alcohol pre-exposure (Beier et al., 2009). Blocking
ﬁbrin accumulation also protected against inﬂammation (Beier
et al., 2009). These data implicate ﬁbrin as an important player
in enhanced inﬂammation and injury mediated by PAI-1 after
alcohol exposure.
FIGURE 2 | Chronic ethanol increases hepatic fibrin(ogen) deposition.
Representative photomicrographs (40×) depicting immunoﬂuorescent
detection of ﬁbrin(ogen) ECM are shown. Liver tissue is from mice fed
either control diet or enteral ethanol diet for 4weeks.
INTEGRINS – MEDIATORS OF CELL-TO-ECM COMMUNICATION
While this group demonstrated a strong correlation between
alcohol-induced ﬁbrin deposition and hepatic inﬂammation and
injury, the mechanism(s) by which ﬁbrin is mediating its inﬂam-
matory effects remain unclear. One mechanism by which ﬁbrin
accumulation mediates inﬂammatory effects is via interaction
with cell surface receptors such as integrins. Integrins are het-
erodimeric receptors expressed on many cell types including
endothelial cells, inﬂammatory cells including macrophages and
neutrophils, and platelets. Upon interaction with extracellular
components, including surrounding matrices and cells, the beta
subunit of an integrin undergoes a rapid conformational change.
This change in integrin structure allows for transfer of informa-
tion across the plasma membrane by activation of intracellular
signaling pathways. Adapter proteins, including Integrin-Linked
Kinase (ILK), are important mediators in signal transduction
downstream of integrin activation and play a role in specify-
ing which signaling cascades are activated within the cell. The
integrins represent a diverse superfamily with at least 24 differ-
ent heterodimers that are important in a variety of cell processes
including proliferation, angiogenesis, and inﬂammation.
Fibrin(ogen) ECM is capable of interacting with the integrin
family of cell surface adhesion receptors, such as the integrin αvβ3
(Cheresh et al., 1989). The role of integrin αvβ3 in tumor angio-
genesis and metastasis is well documented, and stimulation of
the αvβ3 integrin has been shown to contribute to inﬂammation
(Zhou et al., 2009). Integrin αvβ3 is strongly expressed by endothe-
lial cells (Carloni et al., 1996), including those that line the hepatic
sinusoids (HSECs), which is a region that colocalizes with ﬁb-
rin accumulation after alcohol exposure (Figure 2). Integrin αvβ3
binds ﬁbrin(ogen) via an RGD sequence on the protein (Cheresh
et al., 1989),which is pharmacologically targetable with small pep-
tide antagonists. Studies by this group show that inhibition of αvβ3
using the small peptide antagonist, CycloRGDfV, protects against
enhanced LPS-induced liver injury caused by acute alcohol in a“2-
hit”model of acute alcohol-induced liver injury (Figure 3)without
any effects on ﬁbrin accumulation. Additionally, protection from
liver injury by CycloRGDfV was concomitant with the blunting
of LPS-induced neutrophil inﬁltration in this model (Figure 3).
These data suggest that inﬂammation and liver injury due to LPS
after acute alcohol exposure may be due to interaction between
sinusoidal ﬁbrin and integrin αvβ3.
SUMMARY AND CONCLUSION
A safe and effective therapy for ALD in humans is still elusive,
despite signiﬁcant advances in our understanding of how the dis-
ease is initiated and progresses. It is clear that alcohol binges not
only can be acutely toxic to the liver, but also can contribute
to the chronicity of ALD. Potential mechanisms by which acute
alcohol causes damage include steatosis, dysregulated immunity
and inﬂammation, and altered gut permeability. Recent interest
in modeling acute alcohol exposure has yielded new insights into
potential mechanisms of acute injury, that also may well be rele-
vant for chronic ALD. Recent work by this group on the role of
PAI-1 and ﬁbrin metabolism in mediating acute alcohol-induced
liver damage serve as an example of possible new targets that may
be useful for alcohol abuse, be it acute or chronic.
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FIGURE 3 | Inhibition of Integrin αvβ3 protects against enhanced
LPS-induced liver injury caused by ethanol pre-exposure.
Representative photomicrographs (100×; insets 400×) of hematoxylin
and eosin staining are shown in upper panel. Circulating ALT levels and
neutrophil migration (determined by CAE staining) are in the lower left
and right panels, respectively. Animals were exposed to alcohol (6 g/kg
i.g.) for 3 days, followed by LPS administration (10mg/kg; i.p) 24 h after
last dose of ethanol and were sacriﬁced 24 h after ethanol
administration. Some animals received CycloRGDfV (3mg/kg i.p.) 1 h
prior to LPS.
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